Design and formulation of nano-sized spray dried efavirenz-part I: influence of formulation parameters

dc.creatorKatata, Lebogang
dc.creatorTshweu, Lesego
dc.creatorNaidoo, Saloshnee
dc.creatorKalombo, Lonji
dc.creatorSwai, Hulda
dc.date2020-08-31T08:31:42Z
dc.date2020-08-31T08:31:42Z
dc.date2012-10-25
dc.date.accessioned2022-10-25T09:20:26Z
dc.date.available2022-10-25T09:20:26Z
dc.descriptionThis research article published by Springer Nature Switzerland AG.,2012
dc.descriptionEfavirenz (EFV) is one of the first-line antiretroviral drugs recommended by the World Health Organisation for treating HIV. It is a hydrophobic drug that suffers from low aqueous solubility (4 μg/mL), which leads to a limited oral absorption and low bioavailability. In order to improve its oral bioavailability, nano-sized polymeric delivery systems are suggested. Spray dried polycaprolactone-efavirenz (PCL-EFV) nanoparticles were prepared by the double emulsion method. The Taguchi method, a statistical design with an L8 orthogonal array, was implemented to optimise the formulation parameters of PCL-EFV nanoparticles. The types of sugar (lactose or trehalose), surfactant concentration and solvent (dichloromethane and ethyl acetate) were chosen as significant parameters affecting the particle size and polydispersity index (PDI). Small nanoparticles with an average particle size of less than 254 ± 0.95 nm in the case of ethyl acetate as organic solvent were obtained as compared to more than 360 ± 19.96 nm for dichloromethane. In this study, the type of solvent and sugar were the most influencing parameters of the particle size and PDI. Taguchi method proved to be a quick, valuable tool in optimising the particle size and PDI of PCL-EFV nanoparticles. The optimised experimental values for the nanoparticle size and PDI were 217 ± 2.48 nm and 0.093 ± 0.02.
dc.formatapplication/pdf
dc.identifierhttps://doi.org/10.1007/s11051-012-1247-0
dc.identifierhttps://dspace.nm-aist.ac.tz/handle/20.500.12479/891
dc.identifier.urihttp://hdl.handle.net/123456789/94942
dc.languageen
dc.publisherSpringer Nature Switzerland AG.
dc.subjectSpray dried
dc.subjectPolycaprolactone
dc.subjectEfavirenz
dc.subjectNanoparticles
dc.subjectTaguchi method
dc.titleDesign and formulation of nano-sized spray dried efavirenz-part I: influence of formulation parameters
dc.typeArticle

Files